Save your place

Sign in to WhoBought

Please try again later.

Stanley Druckenmiller's Recursion Pharmaceuticals, Inc. (RXRX) position

Not anymore: Stanley Druckenmiller fully exited RXRX in Q1 2024. The position peaked at $15M in Q3 2022.
View full portfolio →
Value at exit
$8.9M
Shares at exit
907K
Est. average buy price (i)
$9.98
est. since Q3 2023
Quarter-end price
$9.86

Estimated trade prices

Average price in quarters with purchases
$13.55

RXRX price vs Druckenmiller's position

1Y 3Y 5Y MAX
Dates
$2$20$4020222023202420252026New position of 260K shares · Q3 2021. Average closing price $28.34 · Price range $19.03–$41.33260KsharespurchasedAdded 14K shares (5.3%) · Q1 2022. Average closing price $10.63 · Price range $6.16–$18.0314KsharespurchasedAdded 1.1M shares (406.5%) · Q3 2022. Average closing price $10.13 · Price range $7.83–$13.601.1Msharespurchased
Average closing price · filing quarter
$10.13
Price range · filing quarter
$7.83 – $13.60
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2024 Exited −907K −$10M −100.0% 0 May 15, 2024
Q4 2023 Unchanged – – – 907K Feb 14, 2024
Q3 2023 First covered – – – 907K Nov 14, 2023
No change · Q4 2022–Q2 2023 (3 quarters)
No change – – – 1.4M –
Q3 2022 Added +1.1M +$11M +406.5% 1.4M Nov 14, 2022
Q2 2022 Unchanged – – – 274K Aug 15, 2022
Q1 2022 Added +14K +$146K +5.3% 274K May 16, 2022
Q4 2021 Unchanged – – – 260K Feb 14, 2022
Q3 2021 New +260K +$7.4M – 260K Nov 15, 2021
Data through Q1 2024 · filed May 15, 2024
9 grouped rows from 11 quarters

More Druckenmiller positions

Natera, Inc.(NTRA)
$613M
20.9% of portfolio

Insmed Incorporated(INSM)
$189M
6.4% of portfolio

Taiwan Semiconductor Manufacturing Company Limited(TSM)
$167M
5.7% of portfolio

YPF Sociedad Anónima(YPF)
an amount we cannot price
5.1% of portfolio

BBB Foods Inc.(TBBB)
an amount we cannot price
3.7% of portfolio

Alcoa Corporation(AA)
$99M
3.4% of portfolio

Common questions

Does Stanley Druckenmiller own RXRX?

Not currently. Stanley Druckenmiller fully exited RXRX in Q1 2024, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Stanley Druckenmiller buy RXRX?

Stanley Druckenmiller first disclosed a RXRX position in Q3 2021; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Stanley Druckenmiller sell RXRX?

Yes. Stanley Druckenmiller reduced and then fully exited RXRX by Q1 2024; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of RXRX does Stanley Druckenmiller own?

None as of the latest filing: Stanley Druckenmiller has exited RXRX. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Stanley Druckenmiller pay for RXRX?

Stanley Druckenmiller began building the RXRX position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.